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Appraisal Research Note
Interpretation of dichotomous outcomes [6_TD$DIFF]: sensitivity, speciﬁcity, likelihood ratios,
and pre-test and post-test probability
Introduction
This is the second Research Note in a two-part series on the
interpretation of statisticalmethods used to analyse dichotomous
outcomes. The ﬁrst paper covered risk, odds, risk ratios, odds
ratios, and number needed to treat. This paper focuses on
sensitivity, speciﬁcity, likelihood ratios, and pre-test and post-
test probability. These additionalmeasures are calculated from2x
2 contingency tables, as were the risk ratios and odds ratios
previously covered. An example of a contingency table is shown in
Box 1.
Sensitivity and speciﬁcity
Sensitivity and speciﬁcity aremeasures that describe howwell
a clinical test performs. They describe the diagnostic performance
of the test in a group of patients by comparing for each patient
their result on the test with whether they actually have the
condition of interest (diagnosis or outcome), as indicated by a
dichotomous reference standard (such as a validated question-
naire, laboratory test, imaging result or clinical outcome such as
death).
Sensitivity is the proportion of people who actually have the
condition of interestwho are correctly identiﬁed by the testwith a
positive result. For example, imagine a hypothetical study (shown
in Box 1)where 500 patientswith low back pain and leg painwere
classiﬁed as having radiculopathy if they were positive on a
reference standard of concordant myotomal weakness, dermato-
mal sensory deﬁcits, diminished reﬂexes and MRI ﬁndings of
nerve root compromise. These 500 patients were also tested with
the Slump Test. Such a study can assess how well the Slump Test
identiﬁes those who have radiculopathy according to the
reference test. Here, the Slump Test is called the ‘index test’ (ie,
the test that is having its diagnostic performance assessed). In this
hypothetical study, 200 patients actually had radiculopathy,
according to the reference test, and 150 of themwere also positive
on the Slump Test (true positives). The sensitivity of the Slump
Test is calculated as the proportion of patients who actually had
radiculopathy on the reference test and who were also correctly
identiﬁed as Slump Test positive: 150/200 = 75%. This means that
three out of four patients who had radiculopathywere positive on
the Slump Test.
Speciﬁcity is the proportion of people who do not have the
condition of interest and who are correctly identiﬁed by the test.
In this hypothetical study, 300 patients did not actually have
radiculopathy, according to the reference test, and 250 of them
were also negative on the Slump Test (true negatives). The
speciﬁcity of the Slump Test is calculated as the proportion of
patients who did not have radiculopathy according to the
reference test and who were correctly identiﬁed as Slump Test
negative: 250/300 = 83%. This means that approximately four out
of ﬁve patients who did not have radiculopathy were negative on
the Slump Test.
Likelihood ratios
Likelihood ratios are another way of calculating the accuracy of
the index test. Likelihood ratios determine howmuchmore likely a
particular test result is among people who have the condition of
interest than it is among people who don’t have the condition.1
There is a likelihood ratio for people who are positive on a test (a
positive likelihood ratio) and a different likelihood ratio for people
who are negative on a test (a negative likelihood ratio). Likelihood
ratios summarise the information contained in both sensitivity and
speciﬁcity.2
A positive likelihood ratio is ameasure of howmuchmore likely
a positive test result is among people who have the condition of
interest than it is among people who do not have the condition of
interest.1 It is calculated as:
sensitivity=ð1specificityÞ
which is equal to:
true positives=ðtrue positivesþ false negativesÞ
1ðtrue negatives=ðtrue negativesþ false positivesÞÞ
In the hypothetical example above, the positive likelihood ratio
would be[7_TD$DIFF]:
ð150=200Þ=ð1ð250=300ÞÞ ¼ 4:5
which indicates that a positive Slump Test is 4.5 times more likely
among people who actually have radiculopathy than among those
who do not have radiculopathy.
A negative likelihood ratio is a measure of how much more
likely a negative test result is among people who have the
condition of interest than it is among people who do not have the
condition of interest.1 It is calculated as:
ð1sensitivityÞ=specificity
which is equal to:
1ðtrue positives=ðtrue positivesþ false negativesÞÞ
true negatives=ðtrue negativesþ false positivesÞ
In the hypothetical example above, the negative likelihood ratio
would be[7_TD$DIFF]:
ð1ð150=200ÞÞ=ð250=300Þ ¼ 0:3
which indicates that a negative Slump Test is about one-third as
likely[1_TD$DIFF] among people who actually have radiculopathy than among
those who do not have radiculopathy.
Likelihood ratios of 1 indicate that the test is uninformative,
whereas likelihood ratios of much more than 1 or closer to
0 indicate that the test is informative.
Likelihood ratios have a number of strengths. One strength is
that they can be combined with the pre-test probability to
calculate the post-test probability of the outcome, as discussed in
the next section. Another strength of likelihood ratios is that they
Journal of Physiotherapy 62 (2016) 231–233
J o u rn a l o f
PHYSIOTHERAPY
journal homepage: www.e lsev ier .com/ locate / jphys
http://dx.doi.org/10.1016/j.jphys.2016.08.008
1836-9553/ 2016 Published by Elsevier B.V. on behalf of Australian Physiotherapy Association. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).
Box 1. Calculation of sensitivity, specificity, predictive values, likelihood ratios, pre-test and post-test probability using hypothetical
data.
In a cross-sectional study involving 500 patients, the diagnostic utility of the ‘Slump Test’ was assessed by comparing it with a
reference test for radiculopathy.
[TD$INLINE]
 Had radiculopathy Had no 
radiculopathy
Row total 
Positive Slump 
Test
150
(true positives) 
50
(false positives) 
200
Negative Slump 
Test
50
(false negatives) 
250
(true negatives) 
300
Column total 200 300 500 
Sensitivity = the probability that the people who have the conditiona will test positive
= true positives / (true positives + false negatives)
= 150 / (150 + 50) = 75% or 0.75
Three out of four patients who had radiculopathy were positive on the Slump Test.
Specificity = the probability that the people who do not have the conditiona will test negative
= true negatives / (true negatives + false positives)
= 250 / (250 + 50) = 83% or 0.83
Approximately four out of five patients who did not have radiculopathy were negative on the
Slump Test.
Pre-test probability = the risk or population prevalence
= 200 / 500 = 40% or 0.40
Two out of five patients in the study had radiculopathy.
Pre-test odds = pre-test probability / (1 – pre-test probability)
= 0.40 / (1 – 0.4) = 67% or 0.67
Positive likelihood ratio = how much more likely a positive test finding is in people who have the conditiona than it is in
people who don’t have the conditiona
= sensitivity / (1 – specificity)
= 0.75 / (1 – 0.83) = 4.5
A positive Slump Test is four and a half times more likely among patients with radiculopathy than
among patients without radiculopathy.
Post-test probability
(positive test result)
= (pre-test odds  positive likelihood ratio) / (1 + (pre-test odds  positive likelihood ratio))
= (0.67  4.5) / (1 + (0.67  4.5))
= 0.75
If a patient in this population has a positive Slump Test, the pre-test estimate of the probability of
radiculopathy (that is, 0.40) can be revised up to 0.75.
Negative likelihood ratio = how much more likely a negative test finding is in people who have the conditiona than it is in
people who don’t have the conditiona
= (1 – sensitivity) / specificity
= (1 – 0.75) / 0.83 = 0.3
A negative Slump Test is about a third as likely among patients with radiculopathy than among
patients without radiculopathy.
Post-test probability
(negative test result)
= (pre-test odds  negative likelihood ratio) / (1 + (pre-test odds  negative likelihood ratio))
= (0.67  0.3) / (1 + (0.67  0.3))
= 0.17
If a patient has a negative Slump Test, the pre-test estimate of the probability of radiculopathy
(that is, 0.40) can be revised down to 0.17.
Italic text presents the interpretation of the statistic from the hypothetical study in sentence format.
a as determined by the reference standard test
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are applicable in populations in which the condition of interest
may have a different prevalence to the population in which the
likelihood ratio was calculated.1 A further strength is that they can
also be used with outcomes that are not dichotomous,1 although
such use is beyond the scope of this paper.
Pre-test and post-test probability
It is useful to know the difference between the pre-test and
post-test probabilities of a certain outcome because this provides a
measure of the value of a clinical test. A large difference between
the post-test probability of the outcome for people with a positive
test result and[8_TD$DIFF] the post-test probability for people with a negative
test result is onemeasure of a clinically useful test. In the context of
a diagnostic study, the pre-test probability is simply the
probability of the diagnosis before the test is performed
(continuing the hypothetical example, the probability of radiculo-
pathy in a particular population before the Slump Test is
performed).
While pre-test and post-test probabilities are easy to interpret
clinically, the journey between them is somewhat convoluted, as
the pre-test probability ﬁrst needs to be converted into a pre-test
odds, which is then multiplied by the likelihood ratio to calculate
the post-test odds, which is then converted into the post-test
probability. Thankfully, simple tools are available so that clinicians
do not need to do themath. Tools such as nomograms and apps are[2_TD$DIFF]
available that require only the pre-test probability and the
likelihood ratio to be input and they will provide the post-test
probability (eg, http://www.sample-size.net/post-probability-
calculator-test-new/).
Box 1 presents a worked example of the calculation of a
likelihood ratio and how this is used to determine the post-test
probability from the pre-test probability. In that hypothetical
example, the pre-test probability is 40%. This indicates that in the
absence of Slump Test results or any other diagnostic information,
the best estimate is that two out of ﬁve patients in the sample have
radiculopathy. The post-test probability for those with a positive
Slump Test is 75% (three out of four patients with a positive Slump
Test have radiculopathy) and for those with a negative Slump Test
is 17% (approximately one out of ﬁve patients with negative Slump
Test has radiculopathy).
The study by Downie et al3 is a real example of using likelihood
ratios to move between the pre-test probability and post-test
probability. This study investigated the change in probability of
having a vertebral fracture if a person presenting with low back
pain had a history of prolonged corticosteroid use. They reported a
likelihood ratio of 48.5. Given a pre-test probability of a person
presenting for care with back pain having a fracture being 1%
(based on previous research), the post-test probability of fracture
in someone who has been exposed to prolonged corticosteroid use
would be calculated to be 33%.
When is a test clinically useful?
The clinical usefulness of a test cannot be determined by either
the sensitivity or speciﬁcity of the test alone; that requires
consideration of both these performancemeasures. It is commonly
believed that when using a test with a high speciﬁcity, a positive
test result is effective at ruling in a condition (SpPIN), and that
when using a test with high sensitivity, a negative test result is
effective at ruling out a condition (SnNOUT).4 While this seems
intuitive, unfortunately it is not that simple5–8 because this does
not work in all scenarios. For example, if a hypothetical test had a
speciﬁcity of 95% (true negatives = 95, false positives = 5) and a
sensitivity of 5% (true positives = 5, false negatives = 95), then the
post-test probabilitywould be the same as the pre-test probability,
so despite the test having high speciﬁcity, it added nothing to
ruling the condition in. A similar scenario would apply to a test
with a very high sensitivity but very low speciﬁcity. As the
calculation of likelihood ratios includes both sensitivity and
speciﬁcity, they are more helpful for determining when a test is
clinically useful. Even though likelihood ratios might not be
intuitive for clinicians, the post-test probabilities that can be
calculated using likelihood ratios are easy to interpret and
straightforward to communicate to patients.
As a rough guide to interpretation, positive likelihood ratios
above 10 are considered to provide strong evidence to rule in a
diagnosis, whereas those between 5 to 10 provide moderate
evidence, and those between 2 and 5 provide weak evidence.9
Conversely, negative likelihood ratios below 0.1 are considered to
provide strong evidence to rule out a diagnosis, whereas those
between 0.1 and 0.2 provide moderate evidence, and those
between 0.2 and 0.5 provide weak evidence.9 However, the impact
of a likelihood ratio is very dependent on the baseline probability.
For example, a likelihood ratio of 10 would result in a post-test
probability of 71% if the pre-test probability were 20%, while the
same likelihood ratio would result in a post-test probability of 17%
if the pre-test probability were 2%. Therefore, likelihood ratios
should always be interpreted in the context of the pre-test
probability of the outcome. A range of factors will inﬂuence how
high the post-test probability for a positive test needs to be before
the test is clinically useful (or how low for a negative test). These
factors include: the consequence of the decision; whether the test
is to be used on its own or in combinationwith other tests; the ease
of performing the test; and the cost and reliability of the test.
Summary
This paper has introduced and explained sensitivity, speciﬁcity,
likelihood ratios, pre-test and post-test probability, in the context
of a diagnostic test. A good understanding of these terms will
enable readers of clinical studies to ensure they correctly interpret
the clinical importance of the ﬁndings reported.
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